Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2018
Cash flows from operating activities of continuing operations:
Net income (loss)	$ (3,838,400)	$ (2,651,397)	$ (1,684,708)	$ (994,482)	$ (6,489,767)	$ (2,679,190)
Amortization of debt discount					1,951,983	1,199,159
Common stock issued in exchange for fees and services					240,501	254,720
Depreciation and amortization	57,116		83,769		115,982	141,156
Loss on disposal of assets					64,095
Loss on settlement of accounts payable						3,750
Loss on settlement of debt						56,093
Provision for doubtful accounts					35,333	3,067
Stock based compensation					395,850	1,234,415
Unrealized (gain) loss on derivative liability					556,647	(1,794,091)
Changes in operating assets and liabilities:
Accounts receivable					74,625	16,067
Prepaid expenses					(142,911)	77,954
Other current assets					33,122	(52,647)
Security deposits					(722)	(451,323)
Operating lease right of use assets					48,332
Accounts payable and accrued liabilities					1,179,775	(348,073)
Customer deposits and deferred revenues					(156,363)	(83,385)
Interest payable					410,712	192,616
Net cash provided by (used in) operating activities					(1,078,049)	(2,148,643)
Cash flows from investing activities:
Cash consideration for acquisition of business						20,468
Notes receivable						(39,987)
Deposit, related party						(200,000)
Purchase of fixed assets					(580,075)	(571,501)
Net cash provided by (used in) investing activities					(580,075)	(791,020)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs					186,000	508,000
Proceeds from issuance of convertible debentures					414,183	6,136,120
Proceeds from issuance of convertible notes, net of issuance costs					971,014
Proceeds from related party advances					199,040
Repayments of capital leases					(93,050)	(22,347)
Repayments of loans payable					(18,617)	(605,348)
Repayments of related party loans payable					(27,151)	(176,528)
Net cash provided by (used in) financing activities					1,631,419	5,839,897
Effect of exchange rates on cash and cash equivalents					(7,769)
Net increase (decrease) in cash and cash equivalents					(34,474)	2,900,234
Cash and cash equivalents at beginning of period		$ 81,735		121,013	81,735	121,013	$ 121,013
Cash and cash equivalents at end of period	$ 47,261		3,021,247		47,261	3,021,247	$ 81,735
Supplemental disclosure of cash flow information:
Cash paid for interest						80,028
Cash paid for income taxes
Supplemental disclosure of non-cash investing and financing activities:
Conversion of convertible note and accrued interest into common stock					708,089	730,485
Reclassification of derivative liability to additional paid in capital			$ 601,139	$ 281,315		882,454
Settlement of account payable for common stock						18,750
Common stock issued for settlement of note payable						162,000
Common stock issued for settlement of related party note payable						62,500
Common stock issued for subscription receivable					406,000
Conversion of Series D Preferred stock to common stock						70
Debt discount recorded on convertible notes and debentures payable upon initial measurement of derivative liability					364,462	5,505,131
Debt discounts recorded for original issue discounts on convertible debentures					846,985	446,800
Equipment financed through capital leases					323,411	385,208
Issuance of convertible notes payable and other obligations in connection with the acquisition of a business						600,000
Sale and assumption of note payable and accrued interest					$ 556,658